ArticleProceedings of the National Academy of Sciences of the United States of America2022

IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer.

Li-Teng Ong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.